Agomab anticipates $182M IPO as it builds fibrosis pipeline
Agomab anticipates $182M IPO as it builds fibrosis pipeline
Body unavailable. Use the original source.
Agomab anticipates $182M IPO as it builds fibrosis pipeline
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.